Chemomab Therapeutics Ltd. Quarterly Common Stock, Shares Authorized from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Chemomab Therapeutics Ltd. quarterly Common Stock, Shares Authorized history and growth rate from Q2 2018 to Q2 2024.
  • Chemomab Therapeutics Ltd. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 4.65B shares, a 615% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.65B +4B +615% Jun 30, 2024 6-K 2024-08-21
Q4 2023 650M 0 0% Dec 31, 2023 6-K 2024-08-21
Q2 2023 650M 0 0% Jun 30, 2023 6-K 2023-08-14
Q1 2023 650M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 650M 0 0% Dec 31, 2022 20-F 2024-03-28
Q3 2022 650M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 650M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 650M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 650M +150M +30% Dec 31, 2021 20-F 2024-03-28
Q3 2021 650M +150M +30% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 650M +150M +30% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 650M +550M +550% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 500M +400M +400% Dec 31, 2020 10-K 2022-03-30
Q3 2020 500M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 500M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 100M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 100M 0 0% Dec 31, 2019 10-K 2021-03-09
Q4 2018 100M Dec 31, 2018 10-K 2020-03-17
Q2 2018 30M Jun 30, 2018 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.